Why the study?
What are the complications and level of therapeutic control associated with long-term anticoagulant therapy in out-patients?
What are the complications and level of therapeutic control associated with long-term anticoagulant therapy in out-patients?
Answers are grounded in this paper and cite their sources.
In outpatients on long-term anticoagulation, warfarin achieved better therapeutic control than phenprocoumon and bishydroxycoumarin, while bleeding risk was associated with lower prothrombin complex activity and older age.
The course of long-term anticoagulant therapy in 114 out-patients has been evaluated over a three-month period. The evaluation was based on the registration of information from the clinical records and from two personal interviews with each patient. The patients had attended the Anticoagulation Clinic for 141 weeks on the average. The prothrombin complex activity (PP%) level was siginificantly lower in patients with bleeding episodes. An apparently higher PP% level in patients with thromboembolic manifestations was not significant. No bleeding was observed when the PP% was above 25. Warfarin resulted in relatively bleeding episodes and more PP% values within the desired range (10-25) than phenprocoumon and bishydroxycoumarin. The role of age, but not of moderate hypertension, as a risk factor was confirmed. A probable adverse interaction of the anticoagulant and other drugs was found in 37.5% of the situations in which an interaction could be expected according to the literature.
No takes yet. Share an insight, caveat, or question.
Husted et al. (1976) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: